Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571
Authors:
- Katarzyna WozniakKWKatarzyna Wozniak
- Agnieszka CzechowskaACAgnieszka Czechowska
- Janusz BlasiakJanusz Blasiak
- 1 April 2004
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 147 (3) , 309-318
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- α‐tocopherol protects against cisplatin‐induced toxicity without interfering with antitumor efficacyInternational Journal of Cancer, 2003
- Possible Involvement of Oxidative Stress in Cisplatin-Induced Apoptosis in LLC-PK1 CellsJournal of Toxicology and Environmental Health, Part A, 2003
- Inhibition of telomerase activity in endometrial cancer cells by selenium‐cisplatin conjugate despite suppression of its DNA‐damaging activity by sodium ascorbateTeratogenesis, Carcinogenesis, and Mutagenesis, 2001
- The BCR/ABL Tyrosine Kinase Induces Production of Reactive Oxygen Species in Hematopoietic CellsJournal of Biological Chemistry, 2000
- Anticlastogenic effect of vitamin C on cisplatin in vivoGenetics and Molecular Biology, 1999
- Single d(GpG)/cis-Diammineplatinum(II) Adduct-Induced Inhibition of DNA PolymerizationBiochemistry, 1998
- The comet assay: mechanisms and technical considerationsMutation Research/DNA Repair, 1996
- Cisplatin Generates Superoxide Anion by Interaction with DNA in a Cell-Free SystemBiochemical and Biophysical Research Communications, 1994
- A simple technique for quantitation of low levels of DNA damage in individual cellsExperimental Cell Research, 1988
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985